NEW YORK (GenomeWeb News) – Stem cell technologies company Cellular Dynamics International today announced it has filed with the US Securities and Exchange Commission to go public.

The Madison, Wis.-based firm filed its Form S-1 with SEC on Monday, saying it plans on an initial public offering to raise a maximum aggregate amount of $57.3 million. The price range for its shares and the number of shares to be offered have not been determined.

JP Morgan Securities is the sole book-running manager on the offering, while Cowen and Co. and Leerink Swann are co-managers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.